COHEN RON 4
4 · ACORDA THERAPEUTICS INC · Filed Dec 4, 2019
Insider Transaction Report
Form 4
COHEN RON
President and CEO
Transactions
- Sale
Common Stock
2019-12-02$1.60/sh−4,699$7,505→ 607,287 total
Holdings
- 25,150(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]Sales pursuant to a 10b5-1 plan. These sales are primarily intended to cover the tax liability resulting from restricted stock vesting.
- [F2]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $1.53 to $1.67 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F3]The shares are held in a grantor retained annuity trust which was established by the reporting person and of which he is the sole trustee.